Clariane SE (XPAR:CLARI) FFO


XPAR:CLARI Clariane SE XPAR:CLARI
60 GF Score
Price €4.23
GF Value €2.49
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Clariane SE FFO?

FFO (Funds from operations) only applies to REITs.

XPAR:CLARI
60GF Score
Clariane SE XPAR:CLARI
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clariane SE (XPAR:CLARI) Overvalued in 2026?

Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued. The current stock price of €4.23 is trading 69.9% above its estimated GF Value™ of €2.49. GuruFocus considers Clariane SE to be Significantly Overvalued.

Key valuation signals for XPAR:CLARI:

  • FFO:
  • GF Value™: €2.49 vs. price of €4.23 (69.9% above fair value)
  • GF Score™: 60/100 with 9 warning signs

No single metric tells the full story. See the XPAR:CLARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clariane SE Business Description

Address 21-25, Rue Balzac, Paris, FRA, 75008
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
60GF Score

Get the complete analysis for XPAR:CLARI

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.23
Price
€2.49
GF Value